Skip to main content

Raiffeisen Bank International AG

Bank

Position in GILD — Gilead Sciences, Inc.

CIK 2044885 VIENNA, C4

Position in GILD

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$25,132,310
-$59,793 QoQ
Shares Held
198,926
+10.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#296
of 2,265 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026
CallValue
$129,877
CallShares
1,028
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $427,125,963 across 9 Drug Manufacturers - General names. GILD ranks #6 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
198,926 $25,132,310

All Filings in GILD

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,132,310 198,926
2026-06-30 $129,877 1,028
2026-03-31 $143,272 1,028
2026-03-31 $25,192,103 180,757
2025-12-31 $24,418,754 198,947
2025-12-31 $126,176 1,028
2025-09-30 $21,559,641 194,231
2025-09-30 $114,108 1,028
2025-06-30 $25,953,447 234,089
2025-03-31 $26,484,921 236,367
2024-12-31 $21,677,021 234,676